UK MenB program for adolescents: New guidance published

The UK Health Security Agency leaflet is a concise, well‑written guide to meningococcal group B (MenB) vaccination for teenagers and young adults in the UK. It explains in plain language why MenB matters, who is eligible now, and what protection the available vaccines offer. Meningococcal disease is rare but devastating. It can present as meningitis or septicaemia and progress very rapidly, even in previously healthy young people. The leaflet reminds readers that around 10% of cases are fatal and many survivors live with life‑changing sequelae such as amputations, hearing loss, brain damage, or extensive scarring. In the UK, group B meningococcus is currently the most common cause of this disease. The document clearly sets out who should receive the MenB vaccine in the current program: pupils in school year 13 and young people born on or after July 21, 2001, who are starting university or moving into halls or other further‑education accommodation...